Alnylam Pharmaceuticals Statistics

Total Valuation

ALNY has a market cap or net worth of $30.08 billion. The enterprise value is $29.01 billion.

Market Cap	30.08B
Enterprise Value	29.01B

Important Dates

The next confirmed earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

ALNY has 126.49 million shares outstanding. The number of shares has increased by 1.63% in one year.

Shares Outstanding	126.49M
Shares Change (YoY)	+1.63%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	92.23%
Float	125.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.02
Forward PS	15.54
PB Ratio	n/a
P/FCF Ratio	235.35
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	226.98

Financial Position

The company has a current ratio of 3.17

Current Ratio	3.17
Quick Ratio	2.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	10.18
Interest Coverage	-1.55

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.90%
Return on Capital (ROIC)	-16.25%
Revenue Per Employee	$953,969
Profits Per Employee	-$158,131
Employee Count	2,100
Asset Turnover	0.54
Inventory Turnover	2.85

Taxes

In the past 12 months, ALNY has paid $7.33 million in taxes.

Income Tax	7.33M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.83% in the last 52 weeks. The beta is 0.37, so ALNY's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+15.83%
50-Day Moving Average	188.40
200-Day Moving Average	170.87
Relative Strength Index (RSI)	61.00
Average Volume (20 Days)	1,944,433

Short Selling Information

The latest short interest is 3.68 million, so 2.91% of the outstanding shares have been sold short.

Short Interest	3.68M
Short Previous Month	2.13M
Short % of Shares Out	2.91%
Short % of Float	2.92%
Short Ratio (days to cover)	2.34

Income Statement

In the last 12 months, ALNY had revenue of $2.00 billion and -$332.08 million in losses. Loss per share was -$2.67.

Revenue	2.00B
Gross Profit	1.68B
Operating Income	-175.80M
Pretax Income	-324.74M
Net Income	-332.08M
EBITDA	-100.79M
EBIT	-197.22M
Loss Per Share	-$2.67

Full Income Statement

Balance Sheet

The company has $2.37 billion in cash and $1.30 billion in debt, giving a net cash position of $1.07 billion or $8.46 per share.

Cash & Cash Equivalents	2.37B
Total Debt	1.30B
Net Cash	1.07B
Net Cash Per Share	$8.46
Equity (Book Value)	-219.27M
Book Value Per Share	-1.73
Working Capital	2.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $189.12 million and capital expenditures -$61.29 million, giving a free cash flow of $127.82 million.

Operating Cash Flow	189.12M
Capital Expenditures	-61.29M
Free Cash Flow	127.82M
FCF Per Share	$1.01

Full Cash Flow Statement

Margins

Gross margin is 83.95%, with operating and profit margins of -8.78% and -16.58%.

Gross Margin	83.95%
Operating Margin	-8.78%
Pretax Margin	-16.21%
Profit Margin	-16.58%
EBITDA Margin	-5.03%
EBIT Margin	-9.84%
FCF Margin	6.38%

Dividends & Yields

ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.63%
Shareholder Yield	-1.63%
Earnings Yield	-1.10%
FCF Yield	0.42%

Dividend Details

Analyst Forecast

The average price target for ALNY is $254.55, which is 7.03% higher than the current price. The consensus rating is "Buy".

Price Target	$254.55
Price Target Difference	7.03%
Analyst Consensus	Buy
Analyst Count	22
Revenue Growth Forecast (5Y)	21.75%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALNY has an Altman Z-Score of 2.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.87
Piotroski F-Score	5